[
  {
    "ts": null,
    "headline": "Abbott Laboratories (NYSE:ABT) Shows Promising Results in Heart Valve Device Study",
    "summary": "Abbott Laboratories (NYSE:ABT) recently announced successful outcomes from its TRILUMINATE™ Pivotal trial for the TriClip™ system, showcasing significant improvements in patient outcomes for tricuspid regurgitation. This medical breakthrough, coupled with Abbott's consistent financial performance, including strong earnings for the fourth quarter of 2024 and strategic dividend announcements, aligns with a 17% rise in its stock price over the last quarter. Despite market turbulences and mixed...",
    "url": "https://finnhub.io/api/news?id=4f059d308dae5b6a0fcd758b5e68a16691013d81f41b9a4d8de1a1336b7425ea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743529057,
      "headline": "Abbott Laboratories (NYSE:ABT) Shows Promising Results in Heart Valve Device Study",
      "id": 133655216,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories (NYSE:ABT) recently announced successful outcomes from its TRILUMINATE™ Pivotal trial for the TriClip™ system, showcasing significant improvements in patient outcomes for tricuspid regurgitation. This medical breakthrough, coupled with Abbott's consistent financial performance, including strong earnings for the fourth quarter of 2024 and strategic dividend announcements, aligns with a 17% rise in its stock price over the last quarter. Despite market turbulences and mixed...",
      "url": "https://finnhub.io/api/news?id=4f059d308dae5b6a0fcd758b5e68a16691013d81f41b9a4d8de1a1336b7425ea"
    }
  },
  {
    "ts": null,
    "headline": "ABT Stock to Gain From Early CE Mark Approval of Volt PFA System",
    "summary": "Abbott achieves early CE Mark approval for the Volt PFA system.",
    "url": "https://finnhub.io/api/news?id=f41ad3db092f673878e5a694e0a7cae46e2eee20da70fb06e53eb42b361409f8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743510420,
      "headline": "ABT Stock to Gain From Early CE Mark Approval of Volt PFA System",
      "id": 133645299,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott achieves early CE Mark approval for the Volt PFA system.",
      "url": "https://finnhub.io/api/news?id=f41ad3db092f673878e5a694e0a7cae46e2eee20da70fb06e53eb42b361409f8"
    }
  },
  {
    "ts": null,
    "headline": "ABT Stock Gains Following the Positive TRILUMINATE Trial Results",
    "summary": "Abbott presents positive TRILUMINATE Pivotal trial data, which demonstrates TriClip system's safety and effectiveness at the ACC.25.",
    "url": "https://finnhub.io/api/news?id=46c17aadac175ed3afd815f08a303c1fc8358d4f284d9a308bacee91211293e1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743506520,
      "headline": "ABT Stock Gains Following the Positive TRILUMINATE Trial Results",
      "id": 133645301,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott presents positive TRILUMINATE Pivotal trial data, which demonstrates TriClip system's safety and effectiveness at the ACC.25.",
      "url": "https://finnhub.io/api/news?id=46c17aadac175ed3afd815f08a303c1fc8358d4f284d9a308bacee91211293e1"
    }
  }
]